REVBW
REVELATION BIOSCIENCES, INC.Warrants of REVELATION BIOSCIENCES, INC. · REVB stock page →
No price
Market cap
$2.3K
Nano cap
1 year
+8.2%
from $3.53 · Nov 17
30 days
+16.4%
from $3.28
52-week range
$3.20–26.57
−86% from high · low Dec 31
Avg volume 20D
21.6K
Oct 20 spike 156.0K
Short interest
2.1K
≈0.3% of shares · −6.6%
Days to cover
1.0
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1
Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
No data for this timeframe.
- Aug 14 ▼ Short interest jumps 45.5% to 5.8K
- Oct 15 ▲ Short interest falls 63.0% to 2.2K
- Oct 19 Trading halt: Trading Halt: REVBW, T1 (News Pending)
- Oct 19 Trading halt: Trading Halt: REVBW, T3 (News and Resumption Times)
- Oct 20 Trading halt: Halt Resumed: REVBW, trading resumed after T3 (News and Re…
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q2 2026: 1 added (0 new), 1 trimmed or exited.
- Short sellersSTEADY
Short interest −6.6% to 2.1K shares. 1.0 days to cover, ≈0.3% of shares.
- TrendDOWNTREND
25% below its 50-day average.
Who's buying
13F· Q2 20260
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| CITADEL ADVISORS LLC | TRIM | $116.00 |
| UBS Group AG | DOUBLED | $28.00 |
| UBS Group AG | DOUBLED | $16.00 |
| UBS Group AG | NEAR_EXIT | $3.00 |
| WOLVERINE ASSET MANAGEMENT LLC | DOUBLED | $383.00 |
| Walleye Capital LLC | NEAR_EXIT | $71.00 |
| CITADEL ADVISORS LLC | TRIM | $423.00 |
| WOLVERINE ASSET MANAGEMENT LLC | TRIM | $333.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | None | None | No data | $0.00 |
| Next Q | None | None | No data | $0.00 |
| Current FY | None | None | No data | $0.00 |
| Next FY | None | None | No data | $0.00 |
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Oct 20, 2026 Trading halt
Halt Resumed: REVBW, trading resumed after T3 (News and Resumption Times)
Halted 2026-10-19T23:50:00.000Z | Resumed 2026-10-20T13:05:00.000Z
Jun 30, 2026 Inst.
CITADEL ADVISORS LLC · TRIM
18,716 shares ($116.00)
Jun 30, 2026 Inst.
Jun 1, 2026 SEC UBS Group AG · DOUBLED
3,532 shares ($28.00)
Revelation Biosciences, Inc. filed an 8-K on June 1, 2026, announcing the release of an updated corporate presentation…
8-K · Impact 2/10
Short side
FINRA· Oct 30, 20262,089
shares short
-6.6%
vs prior settlement
1.0
days to cover
≈0.3%
of shares outstanding
Trading halts
| Oct 19, 2026 | Resumption Scheduled | Resumed |
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 20, 2026
Trading halt
Halt Resumed: REVBW, trading resumed after T3 (News and Resumption Times)
Halted 2026-10-19T23:50:00.000Z | Resumed 2026-10-20T13:05:00.000Z
Oct 19, 2026
Trading halt
Trading Halt: REVBW, T1 (News Pending)
Revelation Biosciences Wt | Market: NASDAQ | Code: T1, News Pending
Oct 19, 2026
Trading halt
Trading Halt: REVBW, T3 (News and Resumption Times)
Revelation Biosciences Wt | Market: NASDAQ | Code: T3, News and Resumption Times
Aug 14, 2026
Short interest
Short Interest: REVBW up 46% to 0.0M shares
Settlement 2026-08-14 | Days to cover: 10.24 | ≈0.14% of shares outstanding (est.)
SecBot reports
1 filing · 0 bullish · 0 bearish · 1 neutralAll REVBW filing & press-release reports (1)
- 8-K reportJun 1, 2026